$819 Million is the total value of QVT Financial LP's 50 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| Buy | TESLA INCnote 1.250% 3/0 | $119,008,000 | +147.5% | 20,000,000 | +25.0% | 14.53% | +77.8% | |
| TSLA | Buy | TESLA INCput | $118,407,000 | +148.6% | 276,000 | +525.9% | 14.46% | +78.6% |
| Buy | NIO INCnote 4.500% 2/0 | $47,811,000 | +197.8% | 20,000,000 | +25.0% | 5.84% | +113.8% | |
| SPY | Buy | SPDR S&P 500 ETF TRtr unit | $40,389,000 | +25.2% | 120,603 | +15.3% | 4.93% | -10.1% |
| NIO | Buy | NIO INCput | $37,929,000 | +391.3% | 1,787,400 | +78.7% | 4.63% | +252.7% |
| New | WORKDAY INCnote 0.250%10/0 | $30,812,000 | – | 20,000,000 | +100.0% | 3.76% | – | |
| New | ON SEMICONDUCTOR CORPnote 1.000%12/0 | $24,647,000 | – | 20,509,000 | +100.0% | 3.01% | – | |
| CCL | Buy | CARNIVAL CORPput | $18,216,000 | -5.6% | 1,200,000 | +2.1% | 2.22% | -32.2% |
| BITA | Buy | BITAUTO HLDGS LTDsponsored ads | $14,773,000 | +46.1% | 937,970 | +47.0% | 1.80% | +4.9% |
| New | CLOVIS ONCOLOGY INCnote 4.500% 8/0 | $14,638,000 | – | 15,000,000 | +100.0% | 1.79% | – | |
| New | ILLUMINA INCnote 0.500% 6/1 | $9,048,000 | – | 7,000,000 | +100.0% | 1.10% | – | |
| New | QUDIAN INCnote 1.000% 7/0 | $6,220,000 | – | 8,400,000 | +100.0% | 0.76% | – | |
| New | EAGLE BULK SHIPPING INCnote 5.000% 8/0 | $3,631,000 | – | 4,850,000 | +100.0% | 0.44% | – | |
| BORR | New | BORR DRILLING LTD | $73,000 | – | 132,345 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MAKEMYTRIP LIMITED MAURITIUS | 38 | Q3 2023 | 6.2% |
| NEW YORK TIMES CO | 34 | Q3 2023 | 2.6% |
| ACCELERON PHARMA INC | 32 | Q3 2021 | 2.8% |
| JPMORGAN CHASE & CO | 32 | Q3 2021 | 2.2% |
| SAREPTA THERAPEUTICS INC | 32 | Q3 2023 | 1.1% |
| BIOMARIN PHARMACEUTICAL INC | 32 | Q3 2023 | 0.5% |
| GOLDMAN SACHS GROUP INC | 30 | Q3 2023 | 5.4% |
| ACADIA PHARMACEUTICALS INC | 28 | Q3 2023 | 0.2% |
| WELLS FARGO CO NEW | 27 | Q4 2020 | 1.5% |
| NEXSTAR MEDIA GROUP INC | 26 | Q3 2023 | 3.4% |
View QVT Financial LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| MP Materials Corp. / DE | May 18, 2023 | 8,853,712 | 5.0% |
| Grindrod Shipping Holdings Ltd.Sold out | February 14, 2022 | 0 | 0.0% |
| AEHR TEST SYSTEMSSold out | February 14, 2020 | 0 | 0.0% |
| Arbutus Biopharma CorpSold out | July 12, 2019 | 0 | 0.0% |
| Axovant Gene Therapies Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
| Myovant Sciences Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
| Urovant Sciences Ltd.Sold out | July 12, 2019 | 0 | 0.0% |
| Axovant Sciences Ltd. | March 19, 2019 | 105,952,381 | 58.2% |
| Hunter Maritime Acquisition Corp.Sold out | February 14, 2019 | 0 | 0.0% |
| AGENUS INC | February 14, 2018 | 3,201,263 | 3.2% |
View QVT Financial LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-03-07 |
| SC 13G/A | 2024-03-07 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 4 | 2023-10-02 |
| 144 | 2023-09-28 |
| 13F-HR | 2023-08-14 |
| SC 13D/A | 2023-05-18 |
| 13F-HR | 2023-05-15 |
View QVT Financial LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.